It was reported that miR-200a directly repressed STAT5b expression in both mice and human 30, while miR-134 was showed to inhibit proliferation, survival and xenograft growth in cancer cell and stem-cell by targeting STAT5b and KRAS 31. This evidence concerns the gene STAT5B and cancer.